• HOME
  • Search
Review Articles
Pleotropic effects of hypoxia-inducible factor-prolyl hydroxylase domain inhibitors: are they clinically relevant?
Yu-Hsiang Chou, Szu-Yu Pan, Shuei-Liong Lin
Kidney Res Clin Pract. 2023;42(1):27-38.   Published online November 21, 2022
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Original Articles
Effects of the route of erythropoietin administration on hemoglobin variability and cardiovascular events in hemodialysis patients
Do Hyoung Kim, Young-Ki Lee, Juhee Kim et al.
Kidney Res Clin Pract. 2021;40(4):724-733.   Published online August 31, 2021
Full textFull text    PubreaderPubReader    ePubePub    PDFPDF    
Ferric carboxymaltose versus ferric gluconate in hemodialysis patients: reduction of erythropoietin dose in 4 years of follow-up
Antonio Lacquaniti, Patrizio Pasqualetti, Teresa Casuscelli di Tocco et al.
Kidney Res Clin Pract. 2020;39(3):334-343.   Published online September 30, 2020
Full textFull text    PubreaderPubReader    PDFPDF    
The effect of intravenous ascorbic acid in hemodialysis patients with normoferritinemic anemia
Dae Woong Kang, Chi Yong Ahn, Bong Kwan Ryu, Byung Chul Shin, Jong Hoon Chung, Hyun Lee Kim
Kidney Res Clin Pract. 2012;31(1):48-53.   Published online January 20, 2012
Full textFull text    PubreaderPubReader    PDFPDF    
Comparison of Once-Biweekly Administration of Epoetin-α with Darbepoetin-α in Chronic Kidney Disease Patients Not Receiving Dialysis
So-Young Kim, M.D., Hae-Jin Choi, M.D., Hye-Jin Choi, M.D., Cho-ee Lee, M.D., Seon-Ung Yun, M.D., Jung-Hwan Park, M.D., Jong-Ho Lee, M.D., Jong-Oh Song, M.D. and Young-Il Jo, M.D.
Korean J Nephrol. 2010;29(5):562-569.
Erythropoietin (EPO) Attenuates Renal Injury in an Experimental Model of Cisplatin-induced Nephrotoxicity in Rats
Dae Eun Choi, M.D. Sarah Chung, M.D. Young Mo Lee, M.D., Ph.D. Kwang-Sun Suh, M.D., Ph.D. Ki-Ryang Na, M.D., Ph.D. Young-Tai Shin, M.D., Ph.D. and Kang Wook Lee, M.D., Ph.D.
Korean J Nephrol. 2009;28(2):103-112.
Time-averaged Concentration Hemoglobin and Erythropoietin Requirement According to Hemoglobin of Different Session of HD of the Week
Eun Hee Jang, M.D. Kang Woo Hun, M.D. and Choi So-yeon, M.D.
Korean J Nephrol. 2008;27(3):319-326.
The Protective Effect of Recombinant Human Erythropoietin and N-acetylcysteine in Radiocontrast-Induced Nephrotoxicity
Sarah Chung, M.D., Eui Sik Kim, M.D., Ji Yoon Jung, M.D. Nan Hee Kim, M.D., Dae Eun Choi, M.D., Ki-Ryang Na, M.D. Kang Wook Lee, M.D. and Young-Tai Shin, M.D.
Korean J Nephrol. 2007;26(6):699-704.
Original Article : The Efficacy of Once Weekly Compared with Two or Three Times Weekly Subcutaneous Epoetin Alfa (Espogen®)
Young Ki Lee, M.D., Hyung Seok Lee, M.D., Min Ha Joo, M.D., Seong Gyun Kim, M.D.Jang Won Seo, M.D., Ji Eun Oh, M.D., Jong Woo Yoon, M.D., Ja Ryong Koo, M.D.Hyung Jik Kim, M.D. and Jung Woo Noh, M.D.
Korean J Nephrol. 2007;26(2):220-226.

Kidney Research
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140

Editorial Office
#301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736    Fax: +82-2-3486-8737    E-mail:                

Copyright © 2024 by The Korean Society of Nephrology.

Developed in M2PI

Close layer